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Summary. Cytological studies in the light microscope showed that thioacetamide
(TAA) depressed the mitotic index in cultures of skin fibroblasts at the lowest
concentrations used (100 ,ug/ml). At high concentration (1 mg/ml), TAA tended to
cause aberration in nuclear morphology. Ethylenethiourea (ETU) had no effect on
either mitotic index or nuclear morphology at 1 mg/ml. Fibroblast cultures treated
with 1 mg/ml TAA and cultures grown in the presence of2 mg/ml ETU were studied
by electron microscopy. In some TAA-treated cells there was unfolding ofthe nuclear
membrane and enlargement and granulation of the nucleolus, but these effects were
not correlated. In all cells, TAA caused severe and characteristic damage to the
majority of mitochondria, whether or not there were nuclear aberrations. The
organelle showed extensive swelling of the cristae of the inner membrane and an
increase in matrix density. Ultrastructure of other cell components appeared to be
unaffected by this treatment. In ETU-treated cells some less severe swelling of inner
mitochondrial membranes was seen and only in a minority of cells, whilst all other
cell structures appeared normal. Similar membrane swelling and increase in matrix
density was seen in isolated rat liver mitochondria after incubation with TAA,
indicating a direct antimitochondrial effect of the carcinogen.
When yeast cells were treated with TAA and ETU, primary antimitochondrial
activity of these compounds was apparent from (1) inhibition of growth in non-
fermentable medium, (2) selective blockage of mitochondrial protein synthesis and
(3) induction of mitochondrial mutations. TAA was much more effective than ETU
in all these respects.
THIOACETAMIDE (TAA) and ethylene-
thiourea (ETU) have similarities in their
structural formulae (Fig. 1) but, whereas
TAA readily induces hepatomas in rats
(Fitzburgh & Nelson, 1948), ETU is
claimed to be tumorigenic only after pro-
longed treatment at high doses (Ulland et
al., 1972). Preliminary results indicated
that for a number ofcarcinogens, including
TAA, mitochondria are the primary tar-
gets in yeast cells (Egilsson et al., 1979).
These findings raise two questions: does
the antimitochondrial activity ofTAA and
other carcinogens extend to human cells
and, if so, is the severity of the antimito-
chondrial
potency?
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Fie. 1. Chemical structure of ethylenethio-
turea (i) and thioacetamide (ii).
We have attempted to answer both
questions by investigating the ultrastruc-
ture of human diploid fibroblasts treated
with TAA and ETU. The results provide
prima facie evidence that mitochondria
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are affected, and more by TAA than by
ETU.
To corroborate these findings, the same
compounds have been studied in the yeast
system, in which primary antimitochon-
drial activity is detectable by several tech-
niques not available for human cells
(Wilkie, 1972). Briefly, the test exploits
the ability of yeast cells to dispense with
mitochondrial respiration (e.g. under
anaerobiosis) and grow on the products
of glycolysis. Thus a compound which
selectively or specifically inhibits mito-
chondria will have little or no effect on
yeast growth provided glucose is available.
The same compound would arrest growth
if the carbon source was non-fermentable
(e.g. glycerol) requiring a functional respi-
ratory chain to be metabolized. The initial
step, then, in establishing the primary
mitochondrial activity of a drug is the
arrest of growth in glycerol medium at
concentrations of the drug which permit
growth in glucose mediumn.
Antimitochondrial activity in the case
of a carcinogen or mutagen would be
expected to result from direct or indirect
reaction with mitochondrial DNA, which
could then be affected both in its trans-
cription and replication. The former
effect is detectable as failure of cyto-
chromes aa3 and b to develop, since the
appearance of these respiratory-chain en-
zymes requires synthesis in the mito-
chondria of mitochondrially coded poly-
peptides. Cytochrome c, on the other hand,
is coded by a nuclear gene and synthesized
on cytoplasmic ribosomes and so would be
largely unaffected by the mitochondrial
inhibitor. These effects are readily scorable
from the cytochrome absorption spectra
using whole yeast cells (Fig. 5).
If mitochondrial DNA replication is
disturbed, genetic lesions (deletions) in
this molecule will readily occur giving rise
to respiratory deficiency recognized as
petite colonies from platings on glucose
medium. The petite condition arises spon-
taneously with a high frequency (usually
1%) resulting from extensive deletions of
mitochondrial DNA. This high frequency
distinguishes this category of respiratory
mutant from nuclear mutations. All
petites appear to be irreversible and none
can carry out mitochondrial protein syn-
thesis. Thus absorption spectra show the
presence of cytochrome c and absence of
aa3 and b. For further information on the
petite mutation, see the review of Ber-
nardi (1979).
MATERIALS AND METHODS
Human cell cultures.-All experiments were
carried out on human skin fibroblasts with a
normal diploid karyotype. None of the cells
had undergone more than 20 culture passages.
The donors of the cells were one male child,
aged 2-5 years (A), one male stillborn infant
(B), and a female foetus (C).
Cell cultures were maintained in Eagle's
Minimum Essential Medium (Flow Labora-
tories Ltd) supplemented with 10% foetal
calf serum, 10 mm HEPES buffer, penicillin
(100 iu/ml) and streptomycin (100 ,ug/ml).
For mitotic counts, the cells were trypsin-
ized (0-15% trypsin in Versene) and re-
suspended in growth medium containing 20%
human serum instead of 10% foetal calf
serum, at a concentration of 105 cells/ml.
Aliquots of 1-5 ml of this suspension were
introduced into 30mm plastic Nunclon Petri
dishes containing 1 coverslip each, 1-5 ml of
suspension being placed in each dish. TAA
and ETU stock solutions were made by dis-
solving the compounds in growth medium
which was then Seitz-filtered (0-22/m Milli-
pore filter discs). Appropriate amounts of
medium containing the carcinogens to give
the required final concentration were added
to the dishes at the time ofplating, and equal
volumes of Seitz-filtered growth media were
added to the control dishes.
Partially synchronized cultures were ob-
tained by trypsinizing confluent cultures and
re-seeding at lower cell densities. At the com-
pletion of treatment, cover slips were re-
moved and the cells were fixed in 95%
ethanol and stained by the Feulgen pro-
cedure. Mitoses were scored using an oil-
immersion objective (x 100) and an eyepiece
graticule (Modified Whipple, Graticules Ltd).
TAA was obtained from Sigma Chemical Co.
and ETU from Rohm & Haas Co., Phila-
delphia, Pennsylvania, U.S.A.
Electron microscopy.-Cultures were pre-
pared by inoculating 1-5 ml of suspensions
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containing 105 cells/ml into Nunclon Petri
dishes. TAA and ETU were added to the
culture medium from the Seitz-filtered stock
solutions. After an incubation period of 48 h,
at 37°C, the cells were fixed at room tem-
perature, and embedded in situ, according to
the method of Brinkley et al. (1967) with the
following modifications: monolayers were
washed in Dulbecco A (3) NaCl solution,
fixed in 4%0 paraformaldehyde/glutaralde-
hyde (in 0-IM sodium cacodylate, Na(CH3)2-
AsO2.3H20, and 0-25M sucrose, pH 7.4),
washed x 6 for 5 min each in Dulbecco A
solution, and finally, post-fixed in 1% OS02
(in 01M sodium cacodylate, 0-25M sucrose,
pH 7 4) for 1 h at room temperature. The
cultures were then rapidly dehydrated in35%0
ethanol for 1 min, soaked in a 60% ethanol/
40%0 resin mixture (EMix resin, EMscopes
Laboratories Ltd, Kent) for 5 min, trans-
ferred to a 30%0 ethanol/70%0 resin mixture
for a further 5 min, infiltrated in pure resin
for 5 min and, finally, re-infiltrated in an-
other fresh change of pure resin and poly-
merized for 24 h at 60°C.
Thin sections (60-90 nm) were examined
in an AEI-801 Electron Microscope, at an
acceleration voltage of 60 kV.
Yeast cultures.-18 strains of the yeast
Saccharomyces cerevisiae from the collection
of this laboratory were used. Culture media
contained 1% Difco yeast extract and either
2% D-glucose (YED) or 4%0 glycerol (YEG)
as carbon source. 2% Difco bacto-agar was
used to solidify medium where required.
TAA and ETU were added to autoclaved
medium from stock solutions. In growth tests,
a multiple inoculation procedure was used
(Wilkie, 1972).
Absorption spectra.-Cultures were grown
in shake culture inYED medium to stationary
phase in the presence and absence of TAA
and ETU. Cells were harvested by centrifu-
gation, washed twice in ice-cold distilled
water and resuspended as thick slurry (- 910q
cells/ml) also in distilled water. Absorption
spectra in the 500nm-630nm region were
scanned using a Pye-Unicam SPI800 re-
cording spectrophotometer at room tem-
perature, with a tissue-paper blank.
Petite mutation. - Petite colonies were
scored initially by size and colour on YED
agar, subsequently by velvet-pad transfer to
YEG medium where they failed to grow.
Rat liver mitochondria.-Mitochondria were
prepared according to Chappell & Hunsford
(1972) and incubated as described by Wallis
& Wilkie (1979) for 3 h in the presence and
absence of 20mM TAA. Mitochondria were
then prepared for EM study following the
method of Diala (1978).
RESULTS
Human cells
The effects of TAA and ETU on cell
division are recorded in Table I. ETU, up
to 2 mg/ml in the culture medium, in-
hibited effect on growth and division of
fibroblasts. On the other hand, TAA at
concentrations of 100 and 250 Ktg/ml
depressed the mitotic rate, while in Exp.
2, 1 mg/ml totally blocked cell division
and also caused severe effects on the
nucleus, which showed marked convolu-
tions similar to those described in tumour
cells of malignant melanoma by Hunter
et al. (1978) (Fig. 2c). In Exp. 4, treatment
with 1 mg/ml TAA did not produce this
morphological aberration, but some in-
hibition of mitosis was still apparent
(Table I).
Seven further experiments were carried
out in which the effects of TAA (0.5 and
1 mg/ml) and ETU (1 and 2 mg/ml) on
morphology were directly compared in
cells from the different donors (A, B and
C: see Table I) and under varying con-
TABLE I. Effect of thioacetamide (TAA)
and ethylenethiourea (ETU) on cell divi-
sion in human cell cultures
Cell
Exp. line Treatment
1 A ETU
1000 ,ug/ml
100 ,ug/ml
Control
2 A TAA
1000 ,tg/ml
100 ,ug/ml
Control
3 A TAA
250 ,ug/ml
100 ,ug/ml
Control
4 C TAA
1000 ,ug/ml
ETU
2000 ,tg/ml
Control
Number in
division*
per 5000 cells
67
54
61
0
1
22
62
126
142
Cells observe(d 25-38 h after plating.
14
30
37
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ditions. These inclutded time of exposure,
passage number, and type of serum (20%
human vs 10°/ foetal calf) in the culture
medium. No abnormalities were seen after
treatment with ETU in any of these
cultures, but cells from A, B and C treated
with 1 mg/ml TAA showed cellular and
nuclear contortion, though cells were
probably not killed by this treatment,
since they remained attached to the cover-
slip. Treatment with 0 5 mg/ml TAA pro-
duced no apparent morphological dis-
turbance. Thus the 3 different cell lines
had similar responses to the various
treatments.
Electron mnicroscopy
A high proportion of the mitochondria
in all cells of culture A treated with
1 mg/ml TAA showed structural aberra-
tions, characterized by a dense matrix and
excessive swelling of the inner membrane
(Fig. 3b). In contrast, ETU-treated cells
showed fewer cases ofstructural aberration
in the mitochondria, which were mostly
indistinguishable from mitochondria of
the control cells (Fig. 3c). No other
structural damage was detected in ETU
cultures. The aberration seen in mito-
chondria was mainly inner-membrane
swelling, but this was not as pronounced
as in the TAA-treated cells. Although
these observations were made using only
one human cell line and at selected con-
centrations ofTAA and ETU in the growth
medium, the results were clear-cut and
widely different for the two compounds.
Results obtained with cells from different
donors in the light-microscope studies
justify the extrapolation to other lines.
Nuclear contortion in TAA-treated cells
was recognizable in EM as extensive fold-
ing of the nuclear membrane (Fig. 2c).
The aberration was seen only in some of
the cells. A main point is that in those cells
with no detectable nuclear distortion the
mitochondrial effect was still much in
evidence (Fig. 2d). At the same time, other
membrane structures (including Golgi,
microtubules and microfilaments, lyso-
somes and endoplasmic reticulum) and
overall cellular morphology appeared un-
affected. On the other hand, the nucleolus
tended to be altered in a characteristic
way in these cells, being enlarged with a
distinctive increase in granular elements
compared with the normal nucleolus
(Fig. 2c). Nuclear substructure in ETU-
treated cells appeared normal. More than
200 nuclei were examined in these studies.
It has been reported that the nucleoli of
rat liver cells treated in vivo with TAA
likewise showed a marked increase in the
granular component (Svoboda & Higgin-
son, 1968) a condition thought to be due
to accumulation of RNA in the nucleoli.
At the same time, mitochondria in these
preparations showed an increased matrix
density and poorly developed cristae. It
was possible in our preparations to see an
apparently normal nucleolus in a cell
showing the typical mitochondrial aber-
ration induced by TAA, which suggests
the primary nature of this effect (Fig. 2d).
Rat liver mitochondria
As can be seen in Fig. 4, TAA caused
nmitochondrial aberrations similar to those
of intact cells, namely swollen and dis-
tended membranes (note fragile condition)
with a dense matrix. These findings de-
monstrated that TAA could directly affect
mitochondrial structure.
Yeast systen.
In all strains tested, both TAA and
ETU were more inhibitory to growth in
glycerol medium than in medium with
glucose as carbon source, indicating pri-
mary antimitochondrial action of both
compounds. The minimum inhibitory con-
centration (MIC) of ETU in glycerol
medium was, on average, -.1 mg/ml,
whereas that of TAA was 200 [ig/ml.
General cytotoxicity ofTAA was indicated
by inhibition ofgrowth in glucose medium
at a concentration of 1 mg/ml, but ETU at
maximum solubility (4 mg/ml) did not
arrest growth in glucose, though the rate
of growth was affected in some strains.
The results indicated that both compounds
selectively blocked mitochondria and that
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FIG. 2.-(a, b) Photo micrographs of human fibroblast nuclei (48 h) Feulgen stain, x 1845. (a) control
cell, (b) 2 cells after treatment with 1 mg/ml TAA, showing distorted nuclei. (c, d) Thin-section
EM micrographs of 1 mg/ml TAA-treated fibroblast cells grown for 48 h. (c) unusual coiling
of the nuclear membrane (nm) and the dense, granular nucleolus (nc), x 10,760; (d) typical
swollen mitochrondrion (m) but apparently normal nuclear structures, x 15,380. Rough endoplas-
mic reticulum, rER; Golgi, G; lysosome, L; microfilaments, MF.
(b)
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Fim. 3.-EM comparison of human fibroblast mitochondria. a, control, x 41,700; b, TAA-treated
(1 mg/mi), x 45,800 (the inner mitochondrial membranes are swollen and the mitochondrial matrix
is very dense, relative to the control); c, ETU-treated (2 mg/mi), x 41,700 (slight swelling of
mnembrane cristae, but not grossly different from control).
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FIG. 4. Effect of thioacetamide (TAA) on the ultrastructure of isolated rat liver mitoclhondria. (See
Materials and Methods for procedure.) a, untreated, x 32,000; b, TAA-treated, x 28,800; c, TAA-
treated, x 58,400. Note distended and fragile condition of treated mitochondria and compare
with Fig. 3b.
TAA was more active than ETU in this
respect.
Selective blockage of mitochondria was
further demonstrated by failure of cyto-
chromes aa3 and b to develop during
growth in glucose medium in the presence
ofthe two compounds (Fig. 5). Thus mito-
chondrial protein synthesis was arrested
while cytoplasmic protein synthesis, ex-
emplified by the appearance ofcytochrome
c, continued.
Interaction with mitochondrial DNA
was indicated by these compounds in the
induction of petite mutants (Table II).
Induction by TAA was extensive but the
mutagenic activity of ETU was slight. It
was shown that the increased frequency of
petite mutants in treated cultures was in-
duction and not selection, by micro-
manipulating cells of petite mutants on to
agar blocks containing TAA and ETU. It
was found that the rate of division of
118ANTIMITOCHONDRIAL THIO-COMPOUNDS
FIG. 5. Absorption spectra of whole yeast
cells, haploid Strain D4, grown to stationary
phase in 1% yeast extract, 20% glucose
medium in the absence of inhibitor (a); in
the presence of 0-1 mg/ml TAA (b); 0 5 mg/
ml ETU (c); anid, 2 mg/ml ETU (d).
The cytochrome absorbing region ranges
from 500 nm to 630 nm. The vertical bar
represents 0-1 OD unit and the major
absorption peaks for cytochromes aa3, b,
and c are, respectively, 603 nm, 562 nm and
552 nm. peaks of cytochromes c and b
are seen at 521 nm and 532 nm respec-
tively.
TABLE II.-Alitochondrial mutagenesi8 by
thioacetamide (TAA) andethylenethiourea
(ETU) in Saccharomyces cerevisiae:
induction of petite colony
Com-
pound
TAA
ETU
Control
Concen-
tration
(mg/ml)
0-2
0-5
2-0
Petite
colonies
178
15
38
19
Total
colonies
622
560
1180
1110
petite
28-6
2-7
3-2
1*6
Results listed are for Laboratory Strain D6, but
essentially similar results were obtained ni 3 other
strains: B21, D22 and B41.
mutant cells was not faster than that of
normal cells but was, in fact, slightly
slower in most cases in the presence of
these compounds. Taken together, these
results are strong evidence of selective
inhibition of mitochondrial biogenesis.
DISCUSSION
The tentative conclusion that TAA
selectively affects mitochondrial develop-
ment in human cells is based on the EM
observations that ultrastructural damage
to the organelle was (1) characteristic and
occurred in all cells treated with TAA and
(2) observed in cells where other structures
appeared normal (applies also to ETU).
However, these observations in them-
selves do not provide conclusive evidence
ofprimary antimitochondrial activity, and
it could be argued that the mitochondrial
effects were secondary to more general
toxicity ofTAA. To prove or disprove this
point would be extremely difficult in this
system.
The results with yeast cells were less
equivocal and clearly indicated a selective
reaction by TAA (and to a lesser extent
ETU) with mitochondrial DNA, causing
mutations and affecting biogenesis.
Whether these yeast results support
direct mitochondrial effects in human cells
depends on how readily results from one
eukaryotic cell type can be extrapolated to
another. In view of the striking simi-
larities in function, structure, organization
and reproductive characteristics of all
mitochondria, yeast and human (even to
intrinsic deviations from the accepted
rules in triplet coding) some extrapolation
would appear to be justified. No mito-
chondrial poison is known to affect yeast
and not mammalian mitochondria.
The possibility ofcarcinogens selectively
reacting with mitochondrial DNA was
raised by Graffi and associated (Wunder-
lich et al., 1970) who found that N-methyl-
N-nitrosourea and nitrosodimethylamine
selectively alkylated mitochondrial DNA
rather than nuclear DNA in animals ad-
ministered these carcinogens. Carcino-
genic azo dyes have also been found to
have a preferential affinity for cytoplasmic
structures in mammalian cells (Nagatani,
1960). The sensitivity of mitochondrial
DNA to alkylating agents and other DNA-
reacting compounds may be due to the
unprotected nature of this molecule; it is
not complexed with packaging proteins as
is nuclear DNA but is a naked, circular
molecule.
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This circularity may also be a source of
vulnerability, if the induction of sister-
chromatid exchange, a well established
activity of chemical carcinogens in repli-
cating mammalian chromosomes (Wolff,
1977) is taken into account. Exchange
between circular chromosomes could in-
troduce mechanical problems, leading to
catenated circles and/or large circles con-
taining multiple genomes. Indeed it is
claimed that catenated and other aberrant
mitochondrial DNA molecules are a fea-
ture of certain tumour cells (Clayton &
Smith, 1975). Whether TAA and ETU
primarily react (directly or indirectly)
with mitochondrial DNA of human cells
remains an open question, though our
results are suggestive.
The possible connection between pri-
mary mitochondrial change and onco-
genesis is discussed by Egilsson el al.
(1979) and is based on our findings that
mitochondrial mutagenesis by chemical
carcinogens has apleiotropic effect on cell-
surface characteristics in yeast cells.
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